-- J&J Must Pay $257.6 Million Over Risperdal Marketing, Louisiana Jury Says
-- B y   J e f   F e e l e y   a n d   M a r g a r e t   C r o n i n   F i s k
-- 2010-10-15T00:16:44Z
-- http://www.bloomberg.com/news/2010-10-15/j-j-must-pay-257-6-million-over-risperdal-marketing-louisiana-jury-says.html
Johnson & Johnson must pay $257.6
million to the state of Louisiana for making misleading claims
about the safety of the companyâ€™s Risperdal antipsychotic drug,
a jury concluded.  To contact the reporter on this story:
Jef Feeley in Wilmington at 
 jfeeley@bloomberg.net   To contact the editor responsible for this story:
Peter Blumberg at 
 pblumberg1@bloomberg.net  